InvestSMART

Cynata Therapeutics Limited (ASX: CYP) - Announcements

- Current share price for CYP : $0.011

ASX company news and announcements for Cynata Therapeutics Limited (CYP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cynata Therapeutics Limited (CYP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cynata Therapeutics Limited (CYP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cynata Therapeutics Limited (CYP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Appendix 3Y-Stewart Washer 16 Jun 2020 10:36AM $0.630 $0.011 fallen by 98.25%
$3 Dr Darryl Maher joins Cynata Board 16 Jun 2020 9:55AM $0.615 $0.011 fallen by 98.21%
$3 Block Trade Proceeds to Reduce Director Loans 16 Jun 2020 9:47AM $0.615 $0.011 fallen by 98.21%
$3 Appendix 2A 10 Jun 2020 4:59PM $0.675 $0.011 fallen by 98.37%
$3 Investor Presentation 10 Jun 2020 9:27AM $0.665 $0.011 fallen by 98.35%
$3 Appendix 2A 2 Jun 2020 9:37AM $0.685 $0.011 fallen by 98.39%
$3 Cynata Successfully Completes Share Purchase Plan 27 May 2020 9:08AM $0.670 $0.011 fallen by 98.36%
$3 Ethics Approval to Commence Clinical Trial in COVID-19 8 May 2020 9:17AM $0.655 $0.011 fallen by 98.32%
$3 Cleansing Notice 1 May 2020 11:31AM $0.630 $0.011 fallen by 98.25%
$3 Appendix 2A 1 May 2020 11:30AM $0.630 $0.011 fallen by 98.25%
$3 Share Purchase Plan Booklet 30 Apr 2020 12:15PM $0.650 $0.011 fallen by 98.31%
$3 Cleansing Notice 24 Apr 2020 9:03AM $0.700 $0.011 fallen by 98.43%
$3 Appendix 2A 24 Apr 2020 8:55AM $0.700 $0.011 fallen by 98.43%
$3 Quarterly Activity Report & Appendix 4C 24 Apr 2020 8:31AM $0.700 $0.011 fallen by 98.43%
$3 Cynata announces $5.55m capital raising 22 Apr 2020 11:32AM $0.675 $0.011 fallen by 98.37%
$3 Proposed Issue of Securities 22 Apr 2020 11:31AM $0.675 $0.011 fallen by 98.37%
$3 Trading Halt 20 Apr 2020 10:19AM $0.835 $0.011 fallen by 98.68%
$3 Cynata MSCs beneficial in preclinical ARDS study 17 Apr 2020 9:59AM $0.755 $0.011 fallen by 98.54%
$3 Cynata provides guidance on planned clinical trials 1 Apr 2020 6:08PM $0.745 $0.011 fallen by 98.52%
$3 Market Update & Additional A$618k R&D Tax Refund 11 Mar 2020 9:35AM $0.865 $0.011 fallen by 98.73%
$3 Cynata Receives Japan Patent Notice of Allowance 10 Mar 2020 9:51AM $0.805 $0.011 fallen by 98.63%
$3 Canadian Patent Issued for CYP Unique Stem Cell Technology 3 Mar 2020 9:40AM $0.900 $0.011 fallen by 98.78%
$3 Appendix 4D & Half-Year Financial Statements 20 Feb 2020 3:43PM $1.080 $0.011 fallen by 98.98%
$3 Notice of Allowance from Israel Patent Office 6 Feb 2020 11:10AM $1.145 $0.011 fallen by 99.04%
$3 Cynata Investor Presentation 31 Jan 2020 12:15PM $1.080 $0.011 fallen by 98.98%

351 - 375 of 708 results

Page 15 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.